Results 191 to 200 of about 28,042 (215)

Global genomics in over 4 million individuals prioritizes therapeutic targets for heart failure and its subtypes

open access: yes
Rasooly D   +22 more
europepmc   +1 more source

SGLT2 inhibitor prescription at discharge in very old adults with heart failure irrespective of diabetes status. [PDF]

open access: yesInt J Cardiol Heart Vasc
Esser R   +11 more
europepmc   +1 more source

Heart Failure with Reduced and Mildly Reduced Ejection Fraction: A Network Interpretive Framework of Mechanisms, Phenotypes, and Therapeutic Response. [PDF]

open access: yesInt J Mol Sci
Krasińska B   +13 more
europepmc   +1 more source

Vericiguat in Elderly Patients with Heart Failure and Reduced Ejection Fraction: Clinical Perspectives from Pathophysiology to Implementation. [PDF]

open access: yesJ Clin Med
Rao CM   +13 more
europepmc   +1 more source

Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. [PDF]

open access: yesJACC: Heart Failure, 2016
ObjectivesThis study evaluated the tolerability and feasibility of titration of 2 distinctly acting beta-blockers (BB) in elderly heart failure patients with preserved (HFpEF) and reduced (HFrEF) left ventricular ejection fraction.BackgroundBroad ...
Svetlana Apostolović, Vera Celic
exaly   +2 more sources

Changes of calcium cycling in HFrEF and HFpEF

Mechanobiology in Medicine, 2023
Yunlong Huo
exaly  

Prognostic nutritional index as the predictor of long-term mortality among HFrEF patients with ICD

PACE - Pacing and Clinical Electrophysiology, 2021
Göksel Çinier   +2 more
exaly  

The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population

Journal of Clinical Medicine, 2023
Giuseppe Dattilo   +2 more
exaly  

Home - About - Disclaimer - Privacy